IP Library Patent Application 17980946
Patent Application
App. No. 17/980,946

METHODS FOR TREATING ABNORMAL GROWTHS IN THE BODY USING A FLOW REDUCING IMPLANT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/980,946
Abstract

A flow reducing implant for reducing blood flow in a blood vessel having a cross sectional dimension, the flow reducing implant comprising a hollow element adapted for placement in the blood vessel defining a flow passage therethrough, said flow passage comprising at least two sections, one with a larger diameter and one with a smaller diameter, wherein said smaller diameter is smaller than a cross section of the blood vessel. A plurality of tabs anchor, generally parallel to the blood vessel wall, are provided in some embodiments of the invention.

Claims (32)

1 . (canceled)

2 . A radially expandable implantable device comprising:

a narrowed section having inlet and outlet ends and defining a flow passage therethrough; and

a flared section connected to the inlet end of the narrowed section, wherein:

the device is configured to engage a wall of and to modify blood flow through a blood vessel in an expanded configuration; and

a size of the narrowed section and a size of the flared section are selected to generate a pressure differential across the device sufficient to increase blood flow to a. region of ischemia fluidically connected to the blood vessel.

3 . The device of claim 2 , wherein a ratio of a cross-sectional area of the narrowed section to a cross-sectional area of the flared section is selected to generate the pressure differential across the device sufficient to increase blood flow to the region of ischemia.

4 . The device of claim 3 , wherein the ratio of the cross-sectional area of the narrowed section to the cross-sectional area of the flared section is in a range from approximately 0.2 to approximately 0.9.

5 . The device of claim 2 , wherein an inner diameter of the narrowed section and a maximum inner diameter of the flared section are selected to generate the pressure differential across the device sufficient to increase blood flow to the region of ischemia.

6 . The device of claim 5 , wherein:

the inner diameter of the narrowed section is in a range from approximately 1 mm to approximately 10 mm; and

the maximum inner diameter of the flared section is in a range from approximately 2 mm to approximately 30 mm.

7 . The device of claim 2 , wherein the device is coated with a material that promotes tissue ingrowth.

8 . The device of claim 2 , wherein the narrowed section is configured to decrease blood flow through the blood vessel. (New) The device of claim 8 , wherein the blood vessel is a coronary sinus.

10 . The device of claim 9 , wherein the decrease in the blood flow through the coronary sinus and associated pressure differential across the device is sufficient to cause angiogenesis.

11 . The device of claim 2 , wherein:

the flared section comprises a first portion and a second portion between the first portion and the inlet end of the narrowed section;

the first portion has a substantially constant diameter; and

the second portion and having a diameter that decreases from the first portion to the narrowed section.

12 . The device of claim 11 , wherein the diameter of the second portion decreases continuously from the first portion to the narrowed section.

13 . The device of claim 2 , wherein the flared section is a first flared section and further comprising a second flared section connected to the outlet end of the narrowed section.

14 . The device of claim 13 , wherein:

the second flared section comprises a first portion and a second portion;

the first portion is between the narrowed section and the second portion;

the first portion has a diameter that increases from the outlet end of the narrowed section to the second portion; and

the second portion has a substantially constant diameter

15 . The device of claim 14 , wherein the diameter of the first portion increases continuously from the throat to the second section.

16 . The device of claim 2 , further comprising a plurality of apertures in the flared section and the narrowed section.

17 . The device of claim 16 , wherein the plurality of apertures have a configuration that provides a greater stiffness to the narrowed section than the flared section.

18 . The device of claim 16 . wherein the plurality of apertures have a configuration that allows the flared section to expand to a diameter larger than the narrowed section.

19 . The device of claim 16 , wherein a diameter of the narrowed section is substantially fixed at a size that is predetermined by a configuration of the plurality apertures on the narrowed section.

20 . The device of claim 16 , wherein a length of the plurality of apertures increases as a function of a distance from a center of the narrowed section.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2024
From: NEOVASC MEDICAL LTD.
To: SHOCKWAVE MEDICAL, INC.
Reel/Frame 066942/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2022
From: BEN-MUVHAR, SHMUEL; SHALEV, ILAN; TSEHORI, JONATHAN; DARVISH, NISSIM
To: NEOVASC MEDICAL LTD.
Reel/Frame 061723/0182 →